Olema Pharmaceuticals Files 8-K on Shareholder Matters

Ticker: OLMA · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1750284

Olema Pharmaceuticals, INC. 8-K Filing Summary
FieldDetail
CompanyOlema Pharmaceuticals, INC. (OLMA)
Form Type8-K
Filed DateJun 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: OLMA

TL;DR

Olema Pharma (OLMA) filed an 8-K on shareholder votes. Keep an eye on governance changes.

AI Summary

Olema Pharmaceuticals, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of security holders as of June 10, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and principal executive offices in San Francisco, California.

Why It Matters

This filing indicates that Olema Pharmaceuticals is engaging in corporate actions requiring shareholder approval, which could impact the company's governance and strategic direction.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial distress or operational setbacks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Olema Pharmaceuticals' security holders?

The filing states that the 8-K reports on 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals voted upon.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 10, 2025.

What is Olema Pharmaceuticals' principal executive office address?

The principal executive offices are located at 780 Brannan Street, San Francisco, California, 94103.

In which state is Olema Pharmaceuticals incorporated?

Olema Pharmaceuticals, Inc. is incorporated in Delaware.

What is the company's telephone number?

The company's telephone number, including area code, is (415) 651-3316.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Olema Pharmaceuticals, Inc. (OLMA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing